Jun 01, 2021 / 05:00PM GMT
Matthew Richard Larew - William Blair & Company L.L.C., Research Division - Analyst
Good morning, everyone. Thanks for joining us today and at William Blair's Virtual Growth Stock Conference. My name is Matt Larew. I cover life sciences tools here at William Blair. And I'm here today with Kevin Herde, the CFO of Maravai LifeSciences, the company I co-cover with my colleague, Brian Weinstein.
A quick compliance note before we jump into things, is that for a complete list of disclosures, you can visit our website at williamblair.com.
Questions and Answers:
Matthew Richard Larew - William Blair & Company L.L.C., Research Division - AnalystSo Kevin, while you're not going to walk -- formally walk through a deck today, given that this is a generalist growth stock conference, I do think it would be helpful if you could maybe just provide a brief overview of Maravai, maybe a history of your work in the company, the markets you participate in and how those markets and your participation in them has evolved over time.
Kevin M.
Trustpilot
